Abstract Population : Immunocompetent individuals living in JE-endemic areas Intervention: One dose of live recombinant JE vaccine Comparison: Placebo/no vaccination/other JE vaccine Outcome : Serious adverse events GRADE table AEFI Japanese encephalitis
